News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Genetown
EXACT Sciences Corporation To Present At Two Investor Conferences In September
September 25, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sept. 22, 2006--EXACT Sciences Corporation (NASDAQ: EXAS) announced today that the Company will be presenting at two investor conferences in September.
Twitter
LinkedIn
Facebook
Email
Print
Events
MORE ON THIS TOPIC
Alzheimer’s disease
CTAD 2026: Biogen, AriBio lead the way in slowing cognitive decline in Alzheimer’s
November 18, 2026
·
6 min read
·
Heather McKenzie
Alzheimer’s disease
CTAD 2026: AriBio’s Alzheimer’s candidate slows cognitive decline as monotherapy
November 17, 2026
·
3 min read
·
Nick Paul Taylor
Alzheimer’s disease
Alzheimer’s field looks beyond amyloid as biopharma converges at CTAD 2026
November 16, 2026
·
7 min read
·
Nick Paul Taylor
GLP-1
Altimmune gears up for FDA meeting on pivotal Phase 3 trial in alcohol use disorder
November 10, 2026
·
2 min read
·
Nick Paul Taylor